Merck to Acquire Harpoon Therapeutics, Further Diversifying Oncology Pipeline

Acquisition includes HPN328, an investigational delta-like ligand 3 targeting T-cell engager being evaluated in certain patients with small cell lung cancer and neuroendocrine tumors

...

Related Keywords

United States ,Canada ,Julie Eastland ,Harpoon Therapeutics Inc ,Drug Administration ,Linkedin ,Goodwin Procter ,Merck Co Inc ,Statement Of Merck Co Inc ,Nasdaq ,Centerview Partners ,Exchange Commission ,Covington Burling ,Merck Research Laboratories ,Youtube ,Evercore Group ,Instagram ,Facebook ,Twitter ,Harpoon Therapeutics ,Merck Research ,Activating Construct ,Hart Scott Rodino Antitrust Improvements Act ,Orphan Drug Designation ,Looking Statement ,Looking Statements ,Private Securities Litigation Reform Act ,Quarterly Report ,Markets ,